(Date:11/23/2009)...lation of arsenic compounds appears to cause oxida...ity, according to a new study published online Nov...stitute . , Although biomethylation was once bel...ught to enhance its toxicity and potentially its c...c biomethylation in oxidative DNA damage in mice, ...
(Date:11/23/2009)...s saw their odds drop by 63 percent with moderate-...ov. 23 (HealthDay News) -- Moderate-to-high intens...ay help reduce stroke risk in older men but not in...d almost 3,300 men and women, average age 69, in M...uring that time, there were 238 strokes among the ...
(Date:11/23/2009)...artnershipswithMinorityBanksin Washington D.C.... S.C. IntendedtoSpurEconomicGrowthandRevitalizati...ire/--DaVita,thenation,sleadingproviderofdialysiss...heAnacostiacommunityfora$1millioninvestmentinIndus...oritycommunities. ,, DaVita,sinvestmentinWashin...
(Date:11/23/2009)...LLAS,Nov.23/PRNewswire/-- ,, WHAT: ,, The...erylCompanies, thenation,sleadinghealthcareexclus...tivelyreachconsumersineverygenerationwithapositive...erCEOofMinuteClinic,thisWebinarwillsupplementHowe,...nalPerspective,"whichdiscusseshowconsumerswillulti...
(Date:11/23/2009)...WYORK,Nov.23/PRNewswire/--Howistheeconomyaffecting...mp;SaatchiWellnessonWellness&theEconomy,theeco...ftsfromahealthylifestyleofexerciseanddiettoonethat...mate. ,, Thesurvey,smostdramaticfindingwasthech...romatraditionalfocusonhealthandwellbeingtotoday,sm...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3...cians to Share Imaging Stories , , WASHINGTON, M...IC) today unveiled RightScanRightTime.org , a n...g community,s support for public policy that ensur...epresenting more than 100,000 physicians, medical ...
...ampaign for Tobacco-Free Kids , , WASHINGTON, May...toric victory for health and the public,s right to...almost all workplaces, including all restaurants a...te to pass a strong smoke-free law that includes a...
...s safe places, but today they are becoming one of ... best of economic times, security is not the top p... an easy place to cut budget and staff. John Adam... hospital crime firsthand. His company is respons...
...w of more than 2,000 patients coded for Barrett,s ...prevalence of the disease according to researchers...of patients assigned a billing diagnosis code for ...esophagus by contrasting codes from electronic dat...
...KE FOREST, Ill., May 14 Hospira, Inc. (NYSE: HS... medication delivery company, today held its 2009 ...e agenda included votes on three items and an upda...4, a testament to the strong foundation we have es...
...Now On Sale , , DENVER, May 14 arc Thrift Store...s that support people with developmental disabilit... on Friday, June 19th, 2009. Co-chairs Cleo Parker...live with physical and cognitive disabilities. One...
Other Medicine News:Health News:AMIC Unveils RightScanRightTime.org 2Health News:Approval of Wisconsin Smoke-Free Legislation Is Historic Win for Health 2Health News:Top Five Things Hospitals Need to do in Order to Remain Safe and Secure 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 3Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 4Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 5Health News:Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders 2Health News:arc Thrift Stores to Honor Individuals and Businesses Who Support People With Developmental Disabilities 2(Date:11/23/2009)...wswire-FirstCall/-- CryoLife,Inc. (NYSE: CRY ),ani...tissueprocessingcompany,announcedtodaythatitissche...ualHealthCareConferenceatTheNewYorkPalaceHotelonDe...hiefexecutiveofficerofCryoLife,Inc.,willprovideaco...ntsandhostaquestionandanswersessionat4:30p.m.Easte...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--WoundManagementTechnolo...oviderofspecialtymedicalproducts,announcedthatitha...ehensivemanagementbusinessupdatetoillustratethedev...alesincreased33.5%to$102,926vs.Q32008salesof$77,08...o$3,327,892vs.Q32008shareholderequityof$(321,257) ...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...byitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),wil...theongoingphase2btrialofRG7128,afirst-in-classnucl...ronichepatitisCvirus(HCV)infection.Thedecisionwasr...toringCommittee(DMC)ofallavailablesafetydatafromth...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 1Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 1CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 2CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 3... an emerging,research-based pharmaceutical company...ation (FDA) has granted Orphan Drug Designation to...tment of chronic lymphocytic,leukemia (CLL). A Pha...ic,in Rochester, Minnesota where researchers are s...henon E in CLL patients., "The FDA Orphan Drug De...
...a,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced...inical trial with AZ-004 (Staccato(R) loxapine).,A...eloped for the treatment,of acute agitation in pat...za believes the novel, non-invasive nature and rap...inhaled loxapine administration via the,Staccato s...
Other Medicine Technology:Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6